Michael Soth

1.2k total citations
19 papers, 620 citations indexed

About

Michael Soth is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael Soth has authored 19 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Michael Soth's work include Chemical Synthesis and Analysis (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Michael Soth is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Michael Soth collaborates with scholars based in United States, Switzerland and United Kingdom. Michael Soth's co-authors include James S. Nowick, Kimberly D. Stigers, A. Kuglstatter, Yan Lou, David Goldstein, Peter Wipf, Linghao Niu, Sue Jin, Johannes C. Hermann and Minh Diem Vu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Pain.

In The Last Decade

Michael Soth

19 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Soth United States 12 400 313 102 49 44 19 620
Alexander W. Hird United States 15 452 1.1× 748 2.4× 143 1.4× 30 0.6× 35 0.8× 19 1.1k
Yongqin Wan United States 11 373 0.9× 217 0.7× 189 1.9× 20 0.4× 31 0.7× 16 687
Renaud Prudent France 18 687 1.7× 186 0.6× 188 1.8× 91 1.9× 33 0.8× 37 1.1k
Vikki Flemington United Kingdom 6 337 0.8× 106 0.3× 107 1.0× 43 0.9× 47 1.1× 9 546
Jeremy L. Yap United States 16 727 1.8× 256 0.8× 183 1.8× 86 1.8× 22 0.5× 22 867
Jason P. Burke United States 9 698 1.7× 282 0.9× 167 1.6× 149 3.0× 70 1.6× 13 950
René Hersperger Switzerland 14 470 1.2× 194 0.6× 55 0.5× 24 0.5× 47 1.1× 19 687
Guoshun Luo China 17 423 1.1× 301 1.0× 274 2.7× 79 1.6× 15 0.3× 46 858
F. Gessier Switzerland 16 559 1.4× 329 1.1× 213 2.1× 29 0.6× 20 0.5× 25 897
Moshe Weitzberg United States 15 242 0.6× 266 0.8× 62 0.6× 47 1.0× 49 1.1× 28 638

Countries citing papers authored by Michael Soth

Since Specialization
Citations

This map shows the geographic impact of Michael Soth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Soth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Soth more than expected).

Fields of papers citing papers by Michael Soth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Soth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Soth. The network helps show where Michael Soth may publish in the future.

Co-authorship network of co-authors of Michael Soth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Soth. A scholar is included among the top collaborators of Michael Soth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Soth. Michael Soth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hao, Xiaoxin, Na Zhao, Diego A. Pedroza, et al.. (2024). CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 9(20). 3 indexed citations
2.
Fiskus, Warren, Christopher P. Mill, Christine Birdwell, et al.. (2023). Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood Cancer Journal. 13(1). 53–53. 33 indexed citations
3.
Soth, Michael, et al.. (2022). Abstract B020: Reprogramming epithelial-mesenchymal transition and the immune microenvironment in triple-negative breast cancer with epigenetic drugs. Cancer Research. 82(23_Supplement_2). B020–B020. 1 indexed citations
4.
Yap, Timothy A., Ecaterina E. Dumbrava, Jordi Rodón, et al.. (2021). First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 3001–3001. 11 indexed citations
5.
Spencer, Nakia D., Christopher A. Bristow, Meredith A. Miller, et al.. (2021). Abstract 87: Asparagine synthetase (ASNS) expression predicts response to the GLS1 inhibitor IPN60090 in ovarian cancer through selective modulation of redox homeostasis. Cancer Research. 81(13_Supplement). 87–87. 1 indexed citations
6.
Ma, Jiacheng, Paul Acton, Virginie Buggia-Prévot, et al.. (2021). Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments. Pain. 162(10). 2599–2612. 16 indexed citations
7.
Fernandez, Celia, Paul Acton, Virginie Buggia-Prévot, et al.. (2020). Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions. International Journal of Molecular Sciences. 21(14). 4849–4849. 10 indexed citations
8.
Vicente, Javier de, Rémy C. Lemoine, Mark J. Bartlett, et al.. (2014). Scaffold hopping towards potent and selective JAK3 inhibitors: Discovery of novel C-5 substituted pyrrolopyrazines. Bioorganic & Medicinal Chemistry Letters. 24(21). 4969–4975. 20 indexed citations
9.
Jaime‐Figueroa, Saul, Javier de Vicente, Johannes C. Hermann, et al.. (2013). Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2522–2526. 31 indexed citations
10.
Lynch, Stephen M., Johannes C. Hermann, Saul Jaime‐Figueroa, et al.. (2013). Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome. Bioorganic & Medicinal Chemistry Letters. 23(9). 2793–2800. 28 indexed citations
11.
Goldstein, David, A. Kuglstatter, Yan Lou, & Michael Soth. (2009). Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders. Journal of Medicinal Chemistry. 53(6). 2345–2353. 146 indexed citations
12.
Billedeau, Roland, et al.. (2009). Synthesis of Heteroaryl-fused Pyrazoles as P38 Kinase Inhibitors. Heterocycles. 78(11). 2811–2811. 6 indexed citations
13.
Bunnell, Aaron E., et al.. (2006). Convenient Method for the 3‐Functionalization of Isoindazoles. Synthetic Communications. 36(3). 285–293. 16 indexed citations
14.
Wipf, Peter & Michael Soth. (2002). Synthesis of the C(1)−C(18) Segment of Lophotoxin and Pukalide. Control of 2-Alkenylfuran (E/Z)-Configuration. Organic Letters. 4(10). 1787–1790. 35 indexed citations
15.
Stigers, Kimberly D., Michael Soth, & James S. Nowick. (2000). ChemInform Abstract: Designed Molecules That Fold to Mimic Protein Secondary Structures. ChemInform. 31(22). 1 indexed citations
16.
Stigers, Kimberly D., Michael Soth, & James S. Nowick. (1999). Designed molecules that fold to mimic protein secondary structures. Current Opinion in Chemical Biology. 3(6). 714–723. 187 indexed citations
17.
Soth, Michael. (1999). Relating to and with the Objectified Body. Self & Society. 27(1). 32–38. 1 indexed citations
18.
Soth, Michael & James S. Nowick. (1998). A Peptide/Oligourea/Azapeptide Hybrid That Adopts a Hairpin Turn. The Journal of Organic Chemistry. 64(1). 276–281. 34 indexed citations
19.
Soth, Michael. (1997). Unnatural oligomers and unnatural oligomer libraries. Current Opinion in Chemical Biology. 1(1). 120–129. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander W. Hird Breakdown of academic impact, for papers by Yongqin Wan Breakdown of academic impact, for papers by Renaud Prudent Breakdown of academic impact, for papers by Vikki Flemington Breakdown of academic impact, for papers by Jeremy L. Yap Breakdown of academic impact, for papers by Jason P. Burke Breakdown of academic impact, for papers by René Hersperger Breakdown of academic impact, for papers by Guoshun Luo Breakdown of academic impact, for papers by F. Gessier Breakdown of academic impact, for papers by Moshe Weitzberg
Rankless by CCL
2026